Related Experiment Video
Updated: May 16, 2026

Two- and Three-Dimensional Live Cell Imaging of DNA Damage Response Proteins
Published on: September 28, 2012
DNA damage-specific control of cell death by cryptochrome in p53-mutant ras-transformed cells
Jin Hyup Lee1, Shobhan Gaddameedhi, Nuri Ozturk
1Department of Biochemistry and Biophysics, University of North Carolina, School of Medicine, Chapel Hill, North Carolina 27599, USA.
Abstract:
The main feedback loop driving circadian rhythm in mice is controlled, in part, by the genes encoding the cryptochromes Cry1 and Cry2. Targeted mutation of both Cry1 and Cry2 delay the early onset of tumor formation in p53-null mutant mice. Furthermore, Ras-transformed p53- and Cry-null mouse skin fibroblasts are more sensitive than p53 mutants to apoptotic cell death initiated by agents that activate either the intrinsic or the extrinsic apoptosis pathways. Here, we investigated the effect of Cry1 and Cry2 mutations on cell death by other genotoxic agents that generate alkylated bases, interstrand crosslinks, DNA-protein crosslinks, and double-strand breaks. Both ultraviolet (UV) and the UV mimetic compound oxaliplatin and the radiomimetic compound doxorubicin promoted apoptosis by upregulating the tumor suppressor p73. However, only the UV and oxaliplatin-induced upregulation of p73 mediated by the transcription factor Egr1, but not the doxorubicin-induced upregulation mediated by the transcription factor E2F1, was enhanced by Cry1/Cry2 double mutation. Accordingly, Egr1 downregulation reduced oxaliplatin-induced apoptosis, whereas E2F1 downregulation reduced doxorubicin-induced apoptosis. Our findings establish distinct roles for cryptochromes in intrinsic apoptosis induced by UV mimetic and radiomimetic agents.
Insights
Cryptochromes (Cry1 and Cry2) influence tumor suppression and apoptosis. Cry1/Cry2 mutations enhance apoptosis induced by UV and oxaliplatin via Egr1, but not doxorubicin via E2F1.
Area of Science:
- Molecular Biology
- Cancer Research
- Genetics
Background:
- Circadian rhythm in mice is regulated by cryptochromes (Cry1 and Cry2).
- Cry1/Cry2 mutations delay tumor formation in p53-null mice and increase apoptosis sensitivity in Ras-transformed fibroblasts.
- The role of cryptochromes in genotoxic agent-induced apoptosis requires further investigation.
Purpose of the Study:
- To investigate the impact of Cry1 and Cry2 mutations on apoptosis induced by various genotoxic agents.
- To elucidate the specific pathways and transcription factors involved in cryptochrome-mediated apoptosis.
Main Methods:
- Utilized p53-null and Cry-null mouse skin fibroblasts.
- Administered genotoxic agents including ultraviolet (UV) radiation, oxaliplatin, and doxorubicin.
- Assessed apoptosis induction and the involvement of p73, Egr1, and E2F1.
Main Results:
- UV, oxaliplatin, and doxorubicin induced apoptosis by upregulating p73.
- Cry1/Cry2 double mutation enhanced UV and oxaliplatin-induced p73 upregulation mediated by Egr1.
- Doxorubicin-induced p73 upregulation, mediated by E2F1, was not enhanced by Cry1/Cry2 mutations.
- Egr1 downregulation reduced oxaliplatin-induced apoptosis, while E2F1 downregulation reduced doxorubicin-induced apoptosis.
Conclusions:
- Cryptochromes play distinct roles in apoptosis induced by UV mimetic (oxaliplatin) and radiomimetic (doxorubicin) agents.
- Cry1/Cry2 mutations specifically enhance apoptosis mediated by the Egr1 pathway in response to oxaliplatin.
- Findings highlight the differential involvement of cryptochromes in genotoxic stress response pathways.
Related Concept Videos
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Negative Regulator Molecules
Abnormal Proliferation
Inhibition of Cdk Activity
The Intrinsic Apoptotic Pathway

